logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (ii) Percentage distribution of new outpatient clients by primary drug for each age group

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids3.212.730.939.145.449.551.947.3458612277
Cocaine2.310.721.229.431.830.029.022.630813278
Stimulants4.36.45.23.93.43.12.31.7534023
Hypnotics and sedatives0.81.11.01.21.92.43.110.5254737
Hallucinogens0.20.30.20.20.10.10.00.12303
Volatile substances7.00.90.10.10.10.10.10.04181
Cannabis 80.067.040.225.015.813.211.612.640255458
Other substances 2.21.01.21.21.51.62.05.2196480
Total19211981729991258221982414192874971121274283157

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, LT, HU, MT, NL, AT, PT, SK, FI, SE, UK. 

 Last data available from Spain refer to year of treatment 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008